Insider Holders & Insider Ownership - CRISPR Therapeutics AG (CRSP)

List of insiders holdings for CRISPR Therapeutics AG:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
GLAXOSMITHKLINE PLC
10% Owner
2020-07-10 17:26:333,310,627
0
3,310,627Form 13D
BAYER AKTIENGESELLSCHAFT
Bayer Global Investments B.V.
10% Owner
2020-02-04 16:19:062,954,775
0
2,954,775Form 13D
CELGENE CORP
10% Owner
2018-02-08 16:25:562,800,772
0
2,800,772Form 13D
Vertex Pharmaceuticals (Europe) Ltd
VERTEX PHARMACEUTICALS INC
10% Owner
2020-02-13 16:05:282,690,470
0
2,690,470Form 13G
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Ventures IV LLC
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
2020-09-18 17:05:282,087,120
0
2,087,120Form 13D
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures IV LLC
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
2021-02-16 07:33:521,344,010
0
1,344,010Form 13D
EMSTER KURT VON
Director
2019-01-18 16:32:230
1,171,268
1,171,268Form 4/A
Lundberg Sven Ante
Chief Scientific Officer
2017-02-10 14:16:28505,217
505,617
1,010,834Form 4
George Simeon
Director
2024-02-27 18:39:310
769,196
769,196Form 4
Hadley Harbor Master Investors (Cayman) L.P.
10% Owner
2016-10-24 14:58:09744,380
0
744,380Form 4
Novak Rodger
President
2021-07-01 17:43:55573,007
0
573,007Form 4
Kulkarni Samarth
Chief Executive Officer
2024-02-21 17:45:17220,757
200,000
420,757Form 4
TOMSICEK MICHAEL JOHN
Chief Financial Officer
2021-08-10 20:00:31132,891
0
132,891Form 4
Versant Venture Capital V L.P.
Versant Ventures V LLC
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
10% Owner
2018-04-26 16:44:030
115,645
115,645Form 4
Subramanian Kala
See Remarks
2017-06-19 16:05:3385,000
0
85,000Form 4
Dylan-Hyde Tyler
Chief Legal Officer
2018-01-18 17:38:3667,104
0
67,104Form 4
Ho Tony W
Executive VP, Head of R&D
2021-12-07 20:00:1965,697
0
65,697Form 4
KASINGER JAMES R.
General Counsel and Secretary
2024-02-21 17:45:2265,021
0
65,021Form 4
CAGNONI PABLO J
Director
2019-11-21 16:07:4363,833
0
63,833Form 4
Woiwode Thomas
Director
2018-06-15 21:39:450
30,000
30,000Form 4
Morrow Phuong Khanh
Chief Medical Officer
2023-10-17 17:52:2716,667
0
16,667Form 4
Smith Brendan
Chief Financial Officer
2023-02-22 17:41:4116,547
0
16,547Form 4
COLES N ANTHONY
Director
2017-06-02 16:30:1915,000
0
15,000Form 4
Prasad Raju
Chief Financial Officer
2023-10-17 17:52:5313,832
0
13,832Form 4
Greene John
Director
2023-06-09 17:34:4913,000
0
13,000Form 4
High Katherine A
Director
2023-06-09 17:36:0313,000
0
13,000Form 4
Treco Douglas A
Director
2023-06-09 17:36:4013,000
0
13,000Form 4
Behbahani Ali
Director
2023-06-09 17:48:5713,000
0
13,000Form 4
Fleming Harold Edward
Director
2023-06-09 17:34:0113,000
0
13,000Form 4
Fardis Maria
Director
2023-06-09 17:33:1113,000
0
13,000Form 4
Klein Lawrence Otto
CBO & COO
2022-08-18 17:36:0212,500
0
12,500Form 4
Bolzon Bradley J PhD
Director
2022-06-10 17:35:0912,000
0
12,000Form 4